Güray Saydam

Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study

Francesco Passamonti, Martin Grießhammer, Francesca Palandri et al. · The Lancet Oncology · 2016 · 245 citations

Polycythaemia Vera, Medicine, Pharmacology +2

Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial

Matthew J. Matasar, Marcelo Capra, Muhıt Özcan et al. · The Lancet Oncology · 2021 · 132 citations · Full text

Lymphoid Neoplasia, Medicine, Pharmacology +7

Granulocytic sarcoma: a systematic review.

Asu Fergün Yılmaz, Güray Saydam, Fahri Şahin et al. · PubMed · 2013 · 123 citations · Full text

Hematological Malignancy, Surgical Oncology, Granulocyte +13

The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy

Merve Yılmaz, Fatoş Dilan Köseoğlu, Fahri Şahin et al. · Supportive Care in Cancer · 2019 · 119 citations

Malnutrition, Nutrition, Hematologic Malignancy +8

Clinical side effects during peripheral blood progenitor cell infusion

Ayhan Dönmez, Murat Tombuloğlu, Ayşe Güngör et al. · Transfusion and Apheresis Science · 2007 · 60 citations

Thrombosis, Hematology, Vascular Biology +4